Eugene

[email protected]

LATEST

ANI Pharmaceuticals To Acquire Generic Products, Assets from Amneal, Impax
By

By
ANI Pharmaceuticals, a Baudette, Minnesota-headquartered pharmaceutical company, has agreed to acquire a portfolio of generic products and other assets from Amneal Pharmaceuticals, a Bridgewater, New Jersey-based generic-drug manufacturer, and Impax…

Catalent Announces Leadership Changes in Biologics Biz
By

By
Catalent Pharma Solutions has made leadership changes within its biologics business. The changes follows its $950-million acquisition in 2017 of Cook Pharmica, a Bloomington, Indiana contract development and manufacturing organization…

Camargo Announces New CEO
By

By
Camargo Pharmaceutical Services, a Cincinnati, Ohio-based provider of drug-development services, including 505(b)(2) drug development and global equivalents, has appointed Daniel S. Duffy as the firm’s new Chief Executive Officer. Kenneth…

WuXi Biologics To Invest $392 Million in New Irish Biomfg Facility
By

By
WuXi Biologics, part of WuXi AppTec, a contract service provider, plans to invest EUR 325 million ($392 million) in a new biologics drug-substance manufacturing facility in Mullagharlin, Dundalk, County Louth,…

Avid Bioservices Expanding Process-Development Capabilities
By

By
Avid Bioservices, a Tustin, California-based contract development and manufacturing organization (CDMO) of biopharmaceutical products derived from mammalian cell culture and a wholly owned subsidiary of Peregrine Pharmaceuticals, has provided an…

WuXi STA To Build New R&D Center for APIs/Intermediates
By

By
STA Pharmaceutical, a subsidiary of WuXi AppTec, has signed an investment agreement with the government of Shanghai, Jinshan District, China to build a new research & development (R&D) center. The…

Otsuka Leads Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Otsuka Pharmaceutical. Editor’s Note: This article was updated on a continuous basis for news announced from…

Merck & Co., Gilead, and Roche Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Merck & Co., Gilead Sciences, Roche, AbbVie, and Johnson & Johnson. Editor’s Note: This article…

Bayer To Sell Crop Science Businesses to BASF For Up To $2 Billion
By

By
Bayer has agreed to sell additional crop science businesses to BASF for up to EUR 1.7 billion ($2 billion), following a 2017 sale agreement between the companies. Bayer is in…

Lilly Appoints Immuno-Oncology Lead
By

By
Eli Lilly and Company has appointed Leena Gandhi, MD, PhD, a thoracic oncologist with expertise in immunotherapy and early drug development, to lead immuno-oncology medical development at Lilly Oncology, effective…